Modern technologies for diagnostics and treatment of insulinoma
https://doi.org/10.14341/probl201359536-41
Abstract
References
1. Трофимов В.М., Калинин А.П. Некоторые аспекты диагностики и лечения органического гиперинсулинизма. Клин мед 1991; 3: 102-106.
2. Boukhman M.P., Karam J.H., Saver J., Siperstein A.E., Duh Q.Y., Clark O.H. Insulinoma-Experience from 1950 to 1965. West J Med 1998; 169: 98-104.
3. Guettier J.M., Gorden P. Insulin secretion and insulin-producing tumors. Exp Rev Endocrinol Metabol 2010; 5: 217-227.
4. de Herder W.W., Niederle B., Scoazeс J.Y., Pauwels S. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma. ENETS Guidelines 2007; 6-20.
5. Kulke M.H., Anthony L.B., Bushnell D.L., de Herder W.W., Goldsmith S.J., Klimstra D.S., Marx S.J., Pasieka J.L., Pommier R.F., Yao J.C., Jensen R.T. NANETS Treatment Guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 2010; 39: 735-752.
6. Jensen R.T., Berna M.J., Bingham D.B., Norton J.A. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies. Cancer 2008; 113: Suppl: 1807-1843.
7. Zhao Y.P., Zhan H.X., Zhang T.P., Cong L., Dai M.H., Liao Q., Cai L.X. Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol 2011; 103: 169-174.
8. Rothmund M., Angelini L., Brunt M.L., Farndon J.R., Geelhoed G., Grama D., Herfarth C., Kaplan E.L., Largiader F., Morino F., Peiper H.J., Proye C., Roher H.D., Ruckert K., Kummerle F., Thompson N.W., van Heerden J.A. Surgery for bening insulinoma; an international review. World J Surg 1990; 14: 393-399.
9. Soga J., Yakuwa Y., Osaka M. Insulinoma/hypoglycemic syndrome: a statistical evaluation of 1085 reported cases of a Japanese series. J Exp Clin Cancer Res 1998; 17: 4: 379-388.
10. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. 2-е изд. М 2009.
11. O'Toole D., Grossman A., Gross D., Fave G.D., Barkmanova J., O'Connor J., Pape U.F., Plockinger U. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology 2009; 90: 194-202.
12. Vinik A.I., Woltering E.A., Warner R.R., Caplin M., O'Dorisio T.M., Wiseman G.A., Coppola D., Go L.W. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 2010; 39: 713-734.
13. Oberg K. Pancreatic endocrine tumors. Semin Oncol 2010; 37: 594-618.
14. Machado M.C., da Cunha J.E., Jukemura J., Bacchella T., Penteado S., Abdo E.E., Machado M.A., Herman P., Montagnini A.L., Pinotti H. Insulinoma: diagnostic strategies and surgical treatment. A 22-year experience. Hepatogastroenterology 2001; 48: 39: 854-858.
15. Морозов Ю.А. Сравнительная оценка информативности различных дооперационных методов топической диагностики при инсулиномах. Автореф. дис. ... канд. мед. наук. М 1998.
16. Svab J., Peskova M., Krusina L., Skrha J., Sindelka G. Personal experience with surgical treatment of insulinoma. Rozhl Chir 2001; 80: 2: 77-81.
17. Jensen R.T., Niederle B., Mitry E., Ramage J.K., Steinmuller T., Lewington V., Scarpa A., Sundin A., Perren A., Gross D., O'Connor J.M., Pauwels S., Kloppel G. Gastrinoma (duodenal and pancreatic). Neuroendocrinology 2006; 84: 173-182.
18. Chung J.C., Choi S.H., Jo S.H., Heo J.S., Choi D.W., Kim Y.I. Localization and surgical treatment of the pancreatic insulinomas. ANZ J Surg 2006; 76: 12: 1051-1055.
19. Кузин Н.М., Егоров А.В. Нейроэндокринные опухоли поджелудочной железы: Руководство. М: Медицина 2001.
20. Proye C., Mahaux P., Pattou K, Filoche В., Godchaux J.M., Maunoury V., Palazzo L., Hugh D., Lefebvre J., Paris J.C. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery. 1998; 124: 6: 1134-1143.
21. Zimmer Т., Ziegler K., Liehr R.M. Stölzel U., Riecken E.O., Wiedenmann B. Endosonography of Neuroendocrine Tumors of the Stomach, Duodenum, and Pancreas. Ann NY Acad Sci 1994-1995; 733: 425-437.
22. Нейроэндокринные опухоли. Руководство для врачей. Под ред. M. Caplin, L. Kvols. 2010; 115-117, 122-129, 206, 212.
23. Botella Carretero J.I., Valero Gonzalez M.A., Lahera Vargas M., Arechaga A., de Juan A., Varela Da Costa C., Sancho J. Diagnostic localization of insulinoma and prognostic value of postoperative glycemia monitoring. Med Clin (Barc) 2002; 118: 6: 201-204.
24. Espana-Gomez M.N., Velazquez-Fernandez D., Bezaury P., Sierra M., Pantoja J.P., Herrera M.F. Pancreatic insulinoma: a surgical experience. World J Surg 2009; 33: 1966-1970.
25. Popovici A., Petca A., Grigoroiu M., Nica A. Insulinomas-nesidioblastomas. Clinical experience. Chirurgia (Bucur) 1997; 92: 6: 387-397.
26. Ticmeanu F., Simion S., Croitoru A., Mastalier B., Angelescu M., Seicaru T. Pancreatic insulinomas. Chirurgia (Bucur) 2001; 96: 3: 277-280.
27. Gouya Н., Vignaux O., Augui J., Dousset B., Palazzo L., Louvel A., Chaussade S., Legmann P. CT, Endoscopic Sonography, and a Combined Protocol for Preoperative Evaluation of Pancreatic Insulinomas. Am J Roentgenol 2003; 181: 987-992.
28. Ambacher T., Kasperk R., Schumpelick V. Rational preoperative diagnosis of insulinoma. Chirurgia 1999; 70: 3: 298-301.
29. Jensen R.T., Cadiot G., Brandi M.L., de Herder W.W., Kaltsas G., Komminoth P., Scoazec J.Y., Salazar R., Sauvanet A., Kianmanesh R. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes., and Barcelona Consensus Conference participants Neuroendocrinology 2012; 95: 2: 98-119.
30. Ardengh J.C., Rosenbaum P., Ganc A.J., Goldenberg A., Lobo E.J., Malheiros E.A., Rahal F., Ferrari A.P. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastrointest Endosc 2000; 51: 5: 552-555.
31. Ardengh J.C., Valiati L.H., Geocze S. Identification of insulinomas by endoscopic ultrasonography. Rev Ass Med Bras 2004; 50: 2: 167-171.
32. Эндокринная хирургия. Под ред. И.И. Дедова, Н.С. Кузнецова, Г.А. Мельниченко. М 2011.
33. CT and MRI of the whole body. Eds. J.R. Haaga, V.S. Dogra, M. Forsting, R.C. Gilkeson, H.K. Ha, M. Sundaram 5 ed. 2003; 1637-1646.
34. Baba Y., Miyazono N., Nakajo M., Kanetsuki I., Nishi H., Inoue H. Localization of insulinomas: Comparison of conventional arterial stimulation with venous sampling (ASVS) and superselective ASVS. Acta Radiol 2000; 41: 172-177.
35. Goh B.K., Ooi L.L., Cheow P.C., Tan Y.M.,Ong H.S., Chung Y.F., Chow P.K., Wong W.K., Soo K.C. Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg 2009; 13: 6: 1071-1077.
36. Jyotsna V.P., Rangel N., Pal S., Seith A., Sahni P., Ammini A.C. Insulinoma: Diagnosis and surgical treatment. Retrospective analysis of 31 cases. Indian J Gastroenterol 2006; 25: 5: 244-247.
37. Andronesi A., Tonea A., Andrei S., Herlea V., Lupescu I., Ionescu-Targoviste C., Coculescu M., Fica S., Ionescu M., Gheorghe C., Popescu I. Insulinoma of the pancreas: analysis of a clinical series of 30 cases. Chirurgia (Bucur) 2009; 104: 6: 675-685.
38. Bottger T. Surgical treatment and outcome in insulinoma. Zentralbl Chir 2001; 126: 4: 273-278.
39. Phan G.Q., Yeo C.J., Hruban R.H., Lillemoe K.D., Pitt H.A., Cameron J.L. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2: 5: 472-482.
40. Vezzosi D., Bennet A., Rochaix P., Courbon F., Selves J., Pradere B., Buscail L., Susini C., Caron P. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 2005; 152: 757-767.
41. Norton J.A., Shawker T.H., Doppman J.L., Miller D.L., Fraker D.L., Cromack D.T., Gorden P., Jensen R.T. Localization and surgical treatment of occult insulinomas. Anna Surg Oncol 1990; 212: 615.
42. Gin H., Catargi B., Rigalleau V., Rullier E., Roger P., Tabarin A. Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas. Eur J Endocrinol 1998; 139: 4: 371-377.
43. Klimstra D.S., Modlin I.R., Coppola D., Lloyd R.V., Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010; 39: 707-712.
44. Tonelli F., Fratini G., Nesi G., Tommasi M.S., Batignani G., Falchetti A., Brandi M.L. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg Oncol 2006; 244: 61-70.
45. Apodaca-Torrez F.R., Trivino T., Lobo E.J., Goldenberg A., Benvenuto M.R., Ardeng J.C. Pancreatic insulinomas. Circulat Esp 2006; 80: 1: 3-8.
46. Chen X., Cai W.Y.,Yang W.P., Li H.W. Pancreatic insulinomas: diagnosis and surgical treatment of 74 patients. Hepatobil Pancreat Dis Intern 2002; 1: 3: 458-461.
47. Khasraw M., Gill A., Harrington T., Pavlakis N., Modlin I. Management of advanced neuroendocrine tumors with hepatic metastases. J Clin Gastroenterol 2009; 43: 838-847.
Review
For citations:
Krivko A.A., Mel'nichenko G.A., Kuznetsov N.S., Troshina E.A., Dedov I.I. Modern technologies for diagnostics and treatment of insulinoma. Problems of Endocrinology. 2013;59(5):36-41. (In Russ.) https://doi.org/10.14341/probl201359536-41

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).